TWI834477B - Extract of chenopodium formosanum koidz., preperation method thereof and use for anti-oxidation, anti-cytotoxicity and anti-inflammation - Google Patents
Extract of chenopodium formosanum koidz., preperation method thereof and use for anti-oxidation, anti-cytotoxicity and anti-inflammation Download PDFInfo
- Publication number
- TWI834477B TWI834477B TW112101659A TW112101659A TWI834477B TW I834477 B TWI834477 B TW I834477B TW 112101659 A TW112101659 A TW 112101659A TW 112101659 A TW112101659 A TW 112101659A TW I834477 B TWI834477 B TW I834477B
- Authority
- TW
- Taiwan
- Prior art keywords
- taiwanese
- quinoa
- extraction
- sprout
- patent application
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 82
- 238000000034 method Methods 0.000 title claims description 25
- 206010061218 Inflammation Diseases 0.000 title abstract description 8
- 241001191531 Chenopodium formosanum Species 0.000 title description 2
- 230000003064 anti-oxidating effect Effects 0.000 title 1
- 240000006162 Chenopodium quinoa Species 0.000 claims abstract description 134
- 238000000605 extraction Methods 0.000 claims abstract description 53
- 238000000855 fermentation Methods 0.000 claims abstract description 50
- 230000004151 fermentation Effects 0.000 claims abstract description 50
- 230000035784 germination Effects 0.000 claims abstract description 36
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 24
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 24
- 238000002360 preparation method Methods 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- 238000011081 inoculation Methods 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 16
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 14
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- NPOAOTPXWNWTSH-UHFFFAOYSA-N 3-hydroxy-3-methylglutaric acid Chemical compound OC(=O)CC(O)(C)CC(O)=O NPOAOTPXWNWTSH-UHFFFAOYSA-N 0.000 claims description 12
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 12
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 12
- -1 xanthine nucleoside Chemical class 0.000 claims description 10
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 8
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 7
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 7
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 7
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 claims description 7
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims description 7
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 7
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 claims description 7
- 235000012208 gluconic acid Nutrition 0.000 claims description 7
- 239000000174 gluconic acid Substances 0.000 claims description 7
- 229940055726 pantothenic acid Drugs 0.000 claims description 7
- 235000019161 pantothenic acid Nutrition 0.000 claims description 7
- 239000011713 pantothenic acid Substances 0.000 claims description 7
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 claims description 7
- 229940045145 uridine Drugs 0.000 claims description 7
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 6
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 claims description 6
- LRFVTYWOQMYALW-UHFFFAOYSA-N Xanthine Natural products O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 claims description 6
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 6
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 6
- 229960002591 hydroxyproline Drugs 0.000 claims description 6
- 239000001630 malic acid Substances 0.000 claims description 6
- 235000011090 malic acid Nutrition 0.000 claims description 6
- 239000002777 nucleoside Substances 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 229940075420 xanthine Drugs 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 5
- 229950006191 gluconic acid Drugs 0.000 claims description 4
- 229940099690 malic acid Drugs 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 2
- 238000002474 experimental method Methods 0.000 description 26
- 230000007760 free radical scavenging Effects 0.000 description 26
- 239000000243 solution Substances 0.000 description 26
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 18
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 16
- 238000002835 absorbance Methods 0.000 description 13
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 12
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 12
- 241000219312 Chenopodium Species 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 238000010586 diagram Methods 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000003642 reactive oxygen metabolite Substances 0.000 description 9
- 239000005022 packaging material Substances 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 244000300310 Chenopodium rubrum Species 0.000 description 6
- 235000009332 Chenopodium rubrum Nutrition 0.000 description 6
- 102000003945 NF-kappa B Human genes 0.000 description 6
- 108010057466 NF-kappa B Proteins 0.000 description 6
- 230000003833 cell viability Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 6
- 235000013479 Amaranthus retroflexus Nutrition 0.000 description 5
- 235000004135 Amaranthus viridis Nutrition 0.000 description 5
- 235000009344 Chenopodium album Nutrition 0.000 description 5
- 235000005484 Chenopodium berlandieri Nutrition 0.000 description 5
- 102000004889 Interleukin-6 Human genes 0.000 description 5
- 108090001005 Interleukin-6 Proteins 0.000 description 5
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 5
- 244000062793 Sorghum vulgare Species 0.000 description 5
- 229960004308 acetylcysteine Drugs 0.000 description 5
- 230000002757 inflammatory effect Effects 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 235000019713 millet Nutrition 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 235000015493 Chenopodium quinoa Nutrition 0.000 description 4
- 102000003814 Interleukin-10 Human genes 0.000 description 4
- 108090000174 Interleukin-10 Proteins 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000026731 phosphorylation Effects 0.000 description 4
- 238000006366 phosphorylation reaction Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000235527 Rhizopus Species 0.000 description 3
- 239000005708 Sodium hypochlorite Substances 0.000 description 3
- 102000005747 Transcription Factor RelA Human genes 0.000 description 3
- 108010031154 Transcription Factor RelA Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000010565 inoculated fermentation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 description 2
- 229940119178 Interleukin 1 receptor antagonist Drugs 0.000 description 2
- 102000003777 Interleukin-1 beta Human genes 0.000 description 2
- 108090000193 Interleukin-1 beta Proteins 0.000 description 2
- 102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000012470 diluted sample Substances 0.000 description 2
- 235000021186 dishes Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000003407 interleukin 1 receptor blocking agent Substances 0.000 description 2
- 229940100601 interleukin-6 Drugs 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000007348 radical reaction Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- RLNWRDKVJSXXPP-UHFFFAOYSA-N tert-butyl 2-[(2-bromoanilino)methyl]piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCCC1CNC1=CC=CC=C1Br RLNWRDKVJSXXPP-UHFFFAOYSA-N 0.000 description 2
- 102000003390 tumor necrosis factor Human genes 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 241000219317 Amaranthaceae Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- XYGKGASSKJWLTN-UHFFFAOYSA-N CCCCCCC.CCCCCCC Chemical compound CCCCCCC.CCCCCCC XYGKGASSKJWLTN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- UBORTCNDUKBEOP-UHFFFAOYSA-N L-xanthosine Natural products OC1C(O)C(CO)OC1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102100035100 Transcription factor p65 Human genes 0.000 description 1
- UBORTCNDUKBEOP-HAVMAKPUSA-N Xanthosine Natural products O[C@@H]1[C@H](O)[C@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-HAVMAKPUSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000005911 anti-cytotoxic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 239000002199 base oil Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 230000024346 drought recovery Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000295 fuel oil Substances 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- JQOAQUXIUNVRQW-UHFFFAOYSA-N hexane Chemical compound CCCCCC.CCCCCC JQOAQUXIUNVRQW-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- DATIMHCCPUZBTD-UHFFFAOYSA-N pentane Chemical compound CCCCC.CCCCC DATIMHCCPUZBTD-UHFFFAOYSA-N 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010563 solid-state fermentation Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- UBORTCNDUKBEOP-UUOKFMHZSA-N xanthosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UUOKFMHZSA-N 0.000 description 1
Abstract
本發明提供了一種台灣藜芽萃取物及其製備方法,係依序經由發芽、發酵與萃取製程製備該台灣藜芽萃取物。本發明還提供了一種台灣藜芽萃取物用於抗氧化、抗細胞毒性或抗發炎之用途。The invention provides a Taiwanese quinoa sprout extract and a preparation method thereof. The Taiwanese quinoa sprout extract is prepared through germination, fermentation and extraction processes in sequence. The invention also provides a use of Taiwanese quinoa sprout extract for antioxidant, anti-cytotoxicity or anti-inflammation.
Description
本發明涉及一種台灣藜芽萃取物及其製備方法,特別來說,是一種包含發芽、發酵與萃取製程製備而得該台灣藜芽萃取物與其用於抗氧化、抗細胞毒性或抗發炎之用途。The present invention relates to a Taiwanese quinoa sprout extract and its preparation method. In particular, it is a preparation method including germination, fermentation and extraction processes to prepare the Taiwanese quinoa sprout extract and its use for antioxidant, anti-cytotoxicity or anti-inflammation. .
隨著社會經濟的發展,人類的生產力提高,生活水準也日益增進,人們對於健康食品的需求也日益迫切。現代人由於長期生活作息不規律且飲食不正常,導致身體機能下降,且由於工業發展致使污染增加,產生之懸浮微粒對人體呼吸系統造成損害,尤其是粒徑≦2.5微米(μm)的懸浮微粒稱為「細懸浮微粒(PM2.5) 」,由於會穿過肺泡而進入人體循環系統中且不易排出,對健康造成重大的威脅。With the development of social economy, human productivity has improved, living standards have also improved day by day, and people's demand for healthy food has become increasingly urgent. Modern people's long-term irregular lifestyle and abnormal diet have led to a decline in body functions. Moreover, due to industrial development, pollution has increased, and the suspended particles produced have caused damage to the human respiratory system, especially suspended particles with a particle size of ≦2.5 microns (μm). Known as "fine suspended particulates (PM2.5)", they can pass through the alveoli and enter the human circulatory system and are not easily discharged, posing a major threat to health.
台灣藜(學名: Chenopodium formosanumKoidz.)為莧科藜亞科藜屬之台灣原生種植物。傳統稱為紅藜,於2008年12月正名為台灣藜,是台灣原住民耕作百年以上的傳統作物,其為一年生草本植物,植株生長強健、耐旱性極佳,而其中的穀粒被稱「料理界的紅寶石」。在台灣,紅藜為原住民傳統的糧食作物,多與稻米、糯米或芋頭共煮,成為粽子、竹筒飯,或供作釀造小米酒之用,而非原住民也開始把它與麵粉共煮,成為烘焙和餐飲料理,或與小米共組食品,如紅藜小米粥、紅藜小米酒、紅藜小米甜甜圈。目前在屏東縣瑪家鄉、臺東與花蓮地區原住民有栽種。台灣藜外殼因含具微毒性的「皂素」,導致帶殼食用台灣藜會苦澀、口感差,不易加工食用,也使帶殼台灣藜有攝取量的限制,因此台灣藜在採收後多會去除紅褐色的外殼,然而台灣藜殼富含多種營養素與活性成分,若能連殼食用,對健康應有助益。 Taiwanese Chenopodium (scientific name: Chenopodium formosanum Koidz.) is a native Taiwanese plant of the Chenopodium genus of the Amaranthaceae family, Chenopodium subfamily. Traditionally called red pigweed, it was renamed Taiwanese pigweed in December 2008. It is a traditional crop cultivated by Taiwanese aborigines for more than a hundred years. It is an annual herb with strong plant growth and excellent drought tolerance, and the grains are Called "the ruby of the culinary world." In Taiwan, red quinoa is a traditional food crop of the aborigines. It is often cooked with rice, glutinous rice or taro to become rice dumplings, bamboo tube rice, or used to brew millet wine. Non-aboriginals have also begun to cook it with flour. , into baking and meal dishes, or combined with millet food, such as red quinoa millet porridge, red quinoa millet wine, red quinoa millet donuts. Currently, it is cultivated by aborigines in Majiajia, Taitung and Hualien areas of Pingtung County. The shell of Taiwanese quinoa contains slightly toxic "saponin", which makes Taiwanese quinoa bitter and tastes bad when eaten in the shell, making it difficult to process and eat. It also limits the intake of Taiwanese quinoa. Therefore, there are many Taiwanese quinoas after harvesting. The reddish-brown shell will be removed, but Taiwanese quinoa shells are rich in many nutrients and active ingredients. If eaten with the shell, it should be beneficial to health.
台灣藜除上述飲食之運用外,其是否對人體健康是否有功效,目前仍需要進一步研究,且先前有文獻指出台灣藜之活性成分因不同收穫期、天候狀態、萃取方式等因素影響台灣藜之內部變化,導致成分有所改變。因此,仍需要有研究能針對台灣藜在何種栽種或萃取狀態下的活性成分有何功效,做出進一步分析與研究。In addition to the above dietary uses, whether Taiwanese quinoa has any effect on human health still needs further research. Previous literature has pointed out that the active ingredients of Taiwanese quinoa are affected by factors such as different harvest periods, weather conditions, and extraction methods. Internal changes, resulting in changes in composition. Therefore, there is still a need for further analysis and research on the effectiveness of the active ingredients of Taiwanese quinoa under what cultivation or extraction conditions.
本發明於是提出一種以台灣藜為材料的應用方法,包括所萃取出的台灣藜芽萃取物以及其製備方法,並進一步證實其具有抗氧化、抗細胞毒性與抗發炎之功效。The present invention therefore proposes an application method using Taiwanese quinoa as a material, including the extracted Taiwanese quinoa sprout extract and its preparation method, and further confirms that it has antioxidant, anti-cytotoxic and anti-inflammatory effects.
根據本發明之一實施例,本發明是提供一種台灣藜芽萃取物之製備方法,包含先將一台灣藜經過一發芽製程而成為一台灣藜芽,接著再將該台灣藜芽經過一接菌發酵製程而得到一發酵台灣藜芽,最後將該發酵台灣藜芽以一萃取製程得到一台灣藜芽萃取物,台灣藜芽萃取物是在萃取製程中取一最終水層而得。According to one embodiment of the present invention, the present invention provides a method for preparing a Taiwanese quinoa bud extract, which includes first subjecting a Taiwanese quinoa bud to a germination process to form a Taiwanese quinoa bud, and then subjecting the Taiwanese quinoa bud to an inoculation process. A fermentation process is performed to obtain a fermented Taiwanese quinoa sprout. Finally, the fermented Taiwanese quinoa sprout is subjected to an extraction process to obtain a Taiwanese quinoa sprout extract. The Taiwanese quinoa sprout extract is obtained by taking a final water layer in the extraction process.
根據本發明另一實施例,是提供一種台灣藜芽萃取物,該台灣藜芽萃取物之有效成分包含:焦麩胺酸、葡萄糖酸、尿苷、蘋果酸、黃嘌呤核苷、3-羥基-3-甲基戊二酸、乙醯左旋肉鹼、泛酸以及4-羥脯氨酸。According to another embodiment of the present invention, a Taiwanese quinoa sprout extract is provided. The active ingredients of the Taiwanese quinoa sprout extract include: pyroglutamic acid, gluconic acid, uridine, malic acid, xanthine nucleoside, 3-hydroxy -3-Methylglutaric acid, acetyl-L-carnitine, pantothenic acid and 4-hydroxyproline.
根據本發明又一實施例,是提供一種台灣藜芽萃取物用於製備一具有抗氧化、抗細胞毒性或抗發炎之組合物的用途。According to another embodiment of the present invention, a use of Taiwanese quinoa sprout extract for preparing a composition with antioxidant, anti-cytotoxicity or anti-inflammatory properties is provided.
為使本發明所屬技術領域中具有普通知識者可以進一步了解本發明,在以下的描述中會列出本發明的較佳實施例,並配合圖式,詳細說明本發明內容及所欲實現之效果。In order that those with ordinary knowledge in the technical field to which the present invention belongs can further understand the present invention, the preferred embodiments of the present invention will be listed in the following description, and together with the drawings, the content of the present invention and the effects to be achieved will be described in detail. .
本發明首先提供一種台灣藜芽萃取物的製備方法,包含以下步驟:(A)將一台灣藜經過一發芽製程而成為一台灣藜芽;(B)將該台灣藜芽經過一接菌發酵製程而得到一發酵台灣藜芽;(C)將該發酵台灣藜芽以萃取製程得到一台灣藜芽萃取物。The present invention first provides a preparation method of Taiwanese quinoa sprout extract, which includes the following steps: (A) subjecting a Taiwanese quinoa sprout to a germination process to become a Taiwanese quinoa sprout; (B) subjecting the Taiwanese quinoa sprout to an inoculation fermentation process A fermented Taiwanese quinoa sprout is obtained; (C) the fermented Taiwanese quinoa sprout is subjected to an extraction process to obtain a Taiwanese quinoa sprout extract.
於步驟(A)中,台灣藜可選用任何穀色之台灣藜麥,例如紅藜、紅橘藜、橘藜、紅紫藜、黑藜、白藜,但並不以此為限,於本發明較佳實施例中,是使用未脫殼之台灣藜,以最大限度保留外殼中營養成分。於本發明之一實施例中,發芽製程包含一殺菌步驟、一清洗步驟以及一灑水步驟。殺菌步驟可使用任何不傷及台灣藜的含氯殺菌溶液,例如次氯酸鈉;清洗步驟則以清水或其他類似溶液,以流洗或浸泡等方式將前述殺菌溶液去除,接著將台灣藜瀝乾;灑水步驟較佳是將台灣藜在避光環境中進行,並於一定間隔時間灑水於表面,以促使台灣藜發芽。於本發明較佳實施例中,是選擇發芽第4天之後的台灣藜芽,以獲得最大的萃取物含量,且發芽4天後的台灣藜芽是置於-80℃的冰箱保存。In step (A), the Taiwanese quinoa can be Taiwanese quinoa of any grain color, such as red quinoa, red orange quinoa, orange quinoa, red purple quinoa, black quinoa, and white quinoa, but is not limited thereto. In a preferred embodiment, unhulled Taiwanese quinoa is used to retain the nutrients in the shell to the maximum extent. In one embodiment of the present invention, the germination process includes a sterilization step, a cleaning step and a water sprinkling step. The sterilization step can use any chlorine-containing sterilization solution that does not harm Taiwanese quinoa, such as sodium hypochlorite; the cleaning step uses water or other similar solutions to remove the aforementioned sterilization solution by washing or soaking, and then drain the Taiwanese quinoa; sprinkle The water step is preferably carried out in a light-proof environment, and water is sprinkled on the surface at certain intervals to promote the germination of Taiwanese pigweed. In a preferred embodiment of the present invention, Taiwanese quinoa sprouts are selected after the 4th day of germination to obtain the maximum extract content, and the Taiwanese quinoa sprouts after 4 days of germination are stored in a refrigerator at -80°C.
於步驟(B)中,是將台灣藜芽進行一接菌發酵製程後得到一發酵台灣藜芽。於本發明較佳實施例中,是採用固態發酵,其可以是採用平板發酵或是採用生物反應器發酵。平板發酵製程,包含將該台灣藜芽栽培於一基質上後,施加一輔助液後,再以孢子懸浮液接種於該台灣藜芽上使其發酵培養。培養基可以是包含有不同量自由水(free water)之基質,並能提供一定之氮源,於一實施例中,例如是馬鈴薯葡萄糖瓊脂(Potato Dextrose Agar, PDA)。輔助液包含可幫助發酵之輔助物質,例如蔗糖與緩衝液,於一實施例中,蔗糖濃度為0.1~5%,緩衝液為0.1~5%之KH 2PO 4。孢子懸浮液是採用絲狀真菌(filamentous fungus)之孢子,其特徵是產生較高濃度的蛋白酶(protease),例如是麴黴屬(Aspergillus)(例如是Aspergillus awamari)、根黴屬(Rhizopus)(例如是Rhizopus microspores var. oligosporus)等,但並不以此為限。於一實施例中,接種之菌量為1%~10%(v/w)。若採用生物反應器,則該接菌發酵製程包含將該台灣藜芽置入一生物反應器後,施加一輔助液後,再以孢子懸浮液接種於該台灣藜芽上使其發酵培養。生物反應器例如是具有一容納槽可放置前述培養基,容納槽中具有調節溫度與氣流之功能。請參考第1圖,所繪示為本發明生物反應器之一實施例的示意圖。如第1圖所示,生物反應器具有一容納槽(tank),容納槽中之攪拌軸可連接至一驅動馬達(motor)而調整攪拌速度或設定攪拌時間。生物反應器還設置有一控制器(controller),其可以透過溫度感應器(thermal sensor)感測容納槽之溫度,並可透過一外接之水浴(water bath)而即時(real time)調整容納槽之溫度;於一實施例中,控制器亦具有一氣閥調控(flow meter)以控制容納槽的進氣量與出氣量。於本發明較佳實施例中,發酵溫度是維持在32~38℃,氣流控制在1~3 LPM (liter of air volume/min)。 In step (B), Taiwanese quinoa sprouts are subjected to an inoculation fermentation process to obtain fermented Taiwanese quinoa sprouts. In a preferred embodiment of the present invention, solid-state fermentation is used, which may be flat plate fermentation or bioreactor fermentation. The plate fermentation process includes cultivating the Taiwanese Chenopodium buds on a substrate, applying an auxiliary liquid, and then inoculating the Taiwanese Chenopodium buds with a spore suspension to allow fermentation and culture. The culture medium can be a matrix containing different amounts of free water and can provide a certain nitrogen source. In one embodiment, it is, for example, potato dextrose agar (PDA). The auxiliary liquid includes auxiliary substances that can assist fermentation, such as sucrose and buffer. In one embodiment, the sucrose concentration is 0.1~5%, and the buffer is 0.1~5% KH 2 PO 4 . The spore suspension is made from spores of filamentous fungus, which is characterized by producing a higher concentration of protease, such as Aspergillus (such as Aspergillus awamari), Rhizopus ( For example, Rhizopus microspores var. oligosporus), etc., but are not limited to this. In one embodiment, the amount of inoculated bacteria is 1% to 10% (v/w). If a bioreactor is used, the inoculation and fermentation process includes placing the Taiwanese Chenopodium buds into a bioreactor, applying an auxiliary liquid, and then inoculating the Taiwanese Chenopodium buds with a spore suspension to allow fermentation and culture. For example, the bioreactor has a holding tank for placing the aforementioned culture medium, and the holding tank has functions of adjusting temperature and air flow. Please refer to Figure 1, which is a schematic diagram of an embodiment of a bioreactor of the present invention. As shown in Figure 1, the bioreactor has a tank, and the stirring shaft in the tank can be connected to a drive motor to adjust the stirring speed or set the stirring time. The bioreactor is also equipped with a controller that can sense the temperature of the holding tank through a thermal sensor and adjust the temperature of the holding tank in real time through an external water bath. Temperature; in one embodiment, the controller also has an air valve control (flow meter) to control the air inlet volume and air outlet volume of the accommodation tank. In a preferred embodiment of the present invention, the fermentation temperature is maintained at 32~38°C, and the air flow is controlled at 1~3 LPM (liter of air volume/min).
於步驟(C)中,是將發酵台灣藜芽以一萃取製程得到一台灣藜芽萃取物。於一實施例中,萃取製程依序包含一粗萃取步驟、一濃縮步驟以及一分層萃取步驟。於一實施例中,粗萃取步驟包含使用一醇類(例如乙醇)加入步驟(B)之凍乾樣品中,並萃取兩次以上,而得到一粗萃物。於一實施例中,濃縮步驟例如是一減壓濃縮步驟,包含將前述粗萃物減壓使該醇類揮發至一預定體積後,再加入水以溶解,而得到一濃縮水層。於一實施例中,分層萃取步驟包含以一烷類加入前述濃縮水層萃取後,取一第一水層;接著以一酯類加入該第一水層萃取後,取一第二水層;最後以一醇類加入該第二水層萃取後,取得一最終水層,所得之該最終水層即為本發明之台灣藜芽萃取物。於一實施例中,烷類例如是正戊烷( n-pentane)、正己烷( n-hexane)、正庚烷( n-heptane),較佳為正己烷,但並不以此為限;酯類例如是乙酸乙酯(ethyl acetate);醇類例如是丙醇(Propan-1-ol)、丁醇(butanol),較佳是丁醇。前述各萃取次數為2次以上,較佳為3次。前述各萃取比例較佳皆為1:1(v/v)。 In step (C), Taiwanese quinoa sprouts are fermented through an extraction process to obtain a Taiwanese quinoa sprouts extract. In one embodiment, the extraction process sequentially includes a rough extraction step, a concentration step and a layered extraction step. In one embodiment, the crude extraction step includes adding an alcohol (such as ethanol) to the freeze-dried sample of step (B) and extracting it more than twice to obtain a crude extract. In one embodiment, the concentration step is, for example, a vacuum concentration step, which includes depressurizing the crude extract to volatilize the alcohol to a predetermined volume, and then adding water to dissolve it to obtain a concentrated aqueous layer. In one embodiment, the layered extraction step includes adding an alkane to the aforementioned concentrated aqueous layer for extraction, and then extracting a first aqueous layer; then adding an ester to the first aqueous layer for extraction, and then extracting a second aqueous layer. ; Finally, an alcohol is added to the second water layer for extraction, and a final water layer is obtained. The final water layer obtained is the Taiwanese quinoa sprout extract of the present invention. In one embodiment, the alkane is, for example, n-pentane ( n -pentane), n-hexane ( n -hexane), n-heptane ( n -heptane), preferably n-hexane, but is not limited thereto; ester The alcohol is, for example, ethyl acetate; the alcohol is, for example, propan-1-ol or butanol, preferably butanol. The number of extractions mentioned above is more than 2 times, preferably 3 times. The preferred extraction ratios mentioned above are all 1:1 (v/v).
本發明所得到之台灣藜芽萃取物,具有抗氧化以及抗發炎之功效,能抑制PM2.5所引發的身體毒性,所使用之有效劑量為10-100 ppm,較佳為20-75 ppm。於一實施例中,前述台灣藜芽萃取物之有效成分包含:焦麩胺酸、葡萄糖酸、尿苷、蘋果酸、黃嘌呤核苷、3-羥基-3-甲基戊二酸、乙醯左旋肉鹼、泛酸以及4-羥脯氨酸。於一實施例中,前述台灣藜芽萃取物在有效萃取劑量下(例如25 ppm),該些有效成分之濃度分別如下:焦麩胺酸為20-200 ppb,較佳為50-150 ppb、葡萄糖酸為10-100 ppb,較佳為20-80 ppb、尿苷為1-50 ppb,較佳為5-35 ppb、蘋果酸為1-50 ppb,較佳為3-15 ppb、黃嘌呤核苷為0.1-10 ppb,較佳為0.5-5 ppb、3-羥基-3-甲基戊二酸為0.1-10 ppb,較佳為0.5-2 ppb、乙醯左旋肉鹼為0.01-5 ppb,較佳為0.1-1 ppb、泛酸為0.01-1 ppb,較佳為0.05-0.5 ppb以及4-羥脯氨酸為0.01-1 ppb,較佳為0.05-0.5 ppb。以下將提出相關實施方式以及實驗數據,並以圖式輔助說明本發明台灣藜芽萃取物之功效。The Taiwanese quinoa sprout extract obtained by the present invention has antioxidant and anti-inflammatory effects, and can inhibit the body toxicity caused by PM2.5. The effective dose used is 10-100 ppm, preferably 20-75 ppm. In one embodiment, the active ingredients of the Taiwanese quinoa sprout extract include: pyroglutamic acid, gluconic acid, uridine, malic acid, xanthine nucleoside, 3-hydroxy-3-methylglutarate, acetyl L-carnitine, pantothenic acid and 4-hydroxyproline. In one embodiment, at the effective extraction dosage (for example, 25 ppm) of the aforementioned Taiwanese quinoa sprout extract, the concentrations of the active ingredients are as follows: pyroglutamic acid is 20-200 ppb, preferably 50-150 ppb, Gluconic acid is 10-100 ppb, preferably 20-80 ppb, uridine is 1-50 ppb, preferably 5-35 ppb, malic acid is 1-50 ppb, preferably 3-15 ppb, xanthine Nucleosides are 0.1-10 ppb, preferably 0.5-5 ppb, 3-hydroxy-3-methylglutaric acid is 0.1-10 ppb, preferably 0.5-2 ppb, acetyl L-carnitine is 0.01-5 ppb, preferably 0.1-1 ppb, pantothenic acid is 0.01-1 ppb, preferably 0.05-0.5 ppb, and 4-hydroxyproline is 0.01-1 ppb, preferably 0.05-0.5 ppb. Relevant embodiments and experimental data will be presented below, and diagrams will be used to assist in explaining the efficacy of the Taiwanese quinoa sprout extract of the present invention.
台灣藜芽萃取物之製備方式Preparation method of Taiwan Quinoa sprout extract
步驟(A):發芽:使用未脫殼台灣藜作為原料,以1.25%次氯酸鈉水溶液浸泡10分鐘進行表面殺菌,接續以清水流洗30分鐘去除雜質與次氯酸鈉,並於室溫下浸泡水19 小時後瀝乾,平鋪於塑膠盤中避光,每24小時表面灑水,發芽第4天後採收於-80℃冰箱凍藏。Step (A): Germination: Use unhulled Taiwanese quinoa as raw material, soak in 1.25% sodium hypochlorite aqueous solution for 10 minutes for surface sterilization, then rinse with clean water for 30 minutes to remove impurities and sodium hypochlorite, and soak in water at room temperature for 19 hours. Drain, lay flat in a plastic tray to avoid light, sprinkle water on the surface every 24 hours, harvest after the 4th day of germination and store in -80°C refrigerator.
步驟(B):接菌發酵製程,可以使用「平板發酵」或者「生物反應器發酵」兩種實施方式。Step (B): The inoculation fermentation process can use two implementation methods: "plate fermentation" or "bioreactor fermentation".
1. 平板發酵法:將上述發芽第4天的台灣藜芽菜利用平板進行發酵,首先進行基質預處理,於發芽第4天之台灣藜加入1.3%蔗糖及0.3% KH 2PO 4,用藥勺拌勻後以滅菌釜121℃濕熱滅菌20分鐘,於無菌操作台中降溫至35℃以下待接菌。經滅菌且冷卻後之發芽台灣藜於無菌操作下,填充至無菌培養皿(100×15 mm),每個培養皿中填充20 g濕重樣品,並接種1 mL的10 6孢子/mL少孢根霉( Rhizopus microspores var. oligosporus, BCRC 31996)孢子懸浮液,接菌量為5% (v/w),以藥勺混勻,於35℃、相對濕度 (relative humidity, RH) 80%發酵培養0~10日,並取發酵芽菜第5天進行後續萃取製程。 1. Plate fermentation method: Use the plate to ferment the Taiwanese quinoa sprouts on the 4th day of germination. First, perform matrix pretreatment. Add 1.3% sucrose and 0.3% KH 2 PO 4 to the Taiwanese quinoa sprouts on the 4th day of germination. Use a medical spoon. After mixing thoroughly, sterilize the kettle with moist heat at 121°C for 20 minutes, then lower the temperature to below 35°C on a sterile operating table for inoculation. Sterilized and cooled germinated Taiwanese pigweed was filled into sterile Petri dishes (100×15 mm) under aseptic operation. Each Petri dish was filled with 20 g wet weight sample and inoculated with 1 mL of 10 6 spores/mL oligospores. Rhizopus microspores var. oligosporus ( BCRC 31996) spore suspension, the inoculation amount is 5% (v/w), mix well with a spatula, ferment and culture at 35℃, relative humidity (RH) 80% From 0 to 10 days, the fermented bean sprouts will be taken for the subsequent extraction process on the 5th day.
2. 生物反應器發酵法:將上述發芽第4天的台灣藜芽菜利用如第1圖所示之生物反應器進行發酵,將1.5 kg發芽之台灣藜置入生物反應器之容納槽,並加入1.3%蔗糖及0.3% KH 2PO 4攪拌均勻。接著將整個容納槽體以滅菌袋完整包覆後放入滅菌釜中,以121℃ 濕熱滅菌40 min後,冷卻降溫10 h。待容納槽體與控制器組裝完成後,於饋料口接種75 mL之10 6孢子/mL孢子懸浮液,接菌量為5% (v/w),以攪拌軸攪拌均勻後,於發酵溫度35℃及通氣量2 LPM (liter of air volume/min)下靜置發酵,每日轉動攪拌軸翻動發酵基質一次,以提高產量。 2. Bioreactor fermentation method: Use the bioreactor shown in Figure 1 to ferment the above-mentioned Taiwanese quinoa sprouts on the 4th day of germination. Place 1.5 kg of germinated Taiwanese quinoa into the holding tank of the bioreactor, and Add 1.3% sucrose and 0.3% KH 2 PO 4 and stir evenly. Then, the entire holding tank is completely covered with a sterilization bag and placed into a sterilization kettle. After sterilization with moist heat at 121°C for 40 minutes, it is cooled for 10 hours. After the storage tank and controller are assembled, inoculate 75 mL of 10 6 spores/mL spore suspension at the feeding port with an inoculation amount of 5% (v/w). After stirring evenly with the stirring shaft, set it at the fermentation temperature. Allow for static fermentation at 35°C and a ventilation rate of 2 LPM (liter of air volume/min). Turn the stirring shaft to turn the fermentation substrate once a day to increase yield.
步驟(C):萃取製程:Step (C): Extraction process:
1. 粗萃取步驟 首先,加入10-15倍(重量)之酒精(1:15 =凍乾樣品:酒精),於攪拌 0.5-1 小時後,將抽氣過濾將凍乾樣品分離進行第二次萃取。重複前述步驟3次,以完成3次萃取。 1. Crude extraction step First, add 10-15 times (weight) of alcohol (1:15 = freeze-dried sample: alcohol). After stirring for 0.5-1 hour, use suction filtration to separate the freeze-dried sample for the second extraction. Repeat the previous steps 3 times to complete 3 extractions.
2. 濃縮步驟 將酒精萃取物減壓濃縮至全乾 (圓底瓶必須先洗淨秤重),減壓濃縮後並再次秤重可得知濃縮物重量。取 50-150 mL 二次水回溶 (可以超音波震盪輔佐回溶,每次50 mL 回溶,若是可以回溶就不必再加水)。分裝進離心管,以5000 rpm 離心10分鐘,取上清液(即濃縮水層)進行後續製程。 2. Concentration step Concentrate the alcohol extract under reduced pressure until it is completely dry (the round-bottom bottle must be washed and weighed first). After concentration under reduced pressure and weighing again, the weight of the concentrate can be obtained. Take 50-150 mL of secondary water and re-dissolve (ultrasonic vibration can be used to assist the re-dissolution, 50 mL each time. If it can be re-dissolved, there is no need to add water). Aliquot into centrifuge tubes, centrifuge at 5000 rpm for 10 minutes, and take the supernatant (i.e. concentrated aqueous layer) for subsequent processes.
3. 分層萃取步驟 烷類萃取:準備分液漏斗,倒入上述上清液(溶液的體積不要超過分液漏斗四分之三的容積),接著加入等體積的正己烷(例: 上清液100 mL,則正己烷加入100 mL)。栓好蓋子後將分液漏斗劇烈搖晃使兩不互溶的溶液混合(期間依需要可打開活栓排氣,大約每搖晃五次放氣一次)。將分液漏斗置於架上,打開蓋子静置使分層。密度較大的水層回溶液在下方,上方為正己烷層。靜置時間約10分鐘。將水層回溶液排出至燒杯中,可稍微搖晃分液漏斗使正己烷層沉降。再收集正己烷層至血清瓶中。重複以正己烷進行三次分層萃取,此為正己烷劃分(以下實驗稱Hex組或HEX組)。 3. Layered extraction step Alkane extraction: Prepare a separatory funnel, pour the above supernatant (the volume of the solution should not exceed three-quarters of the volume of the separatory funnel), and then add an equal volume of n-hexane (for example: 100 mL of supernatant, then n-hexane Add 100 mL of alkane). After tightening the lid, shake the separatory funnel vigorously to mix the two immiscible solutions (during this period, you can open the stopcock to deflate as needed, about once every five shakes). Place the separatory funnel on a rack, open the lid and let it sit to allow the layers to separate. The denser water layer back to the solution is at the bottom, and the n-hexane layer is at the top. Let stand for about 10 minutes. Discharge the water layer back into the beaker and shake the separatory funnel slightly to allow the n-hexane layer to settle. Then collect the n-hexane layer into the serum bottle. Repeat three layered extractions with n-hexane, which is n-hexane division (hereinafter referred to as Hex group or HEX group in the experiment).
酯類萃取:將排出至燒杯中的水層回溶液(即第一水層)倒回分液漏斗,加入等體積的乙酸乙酯進行萃取,栓好蓋子後將分液漏斗劇烈搖晃使兩不互溶的溶液混合(期間依需要可打開活栓排氣,大約每搖晃五次放氣一次)。將分液漏斗置於架上,打開蓋子静置使分層。密度較大的水層回溶液在下方,上方為乙酸乙酯層。靜置時間約10分鐘。將水層回溶液排出至燒杯中,可稍微搖晃分液漏斗使乙酸乙酯層沉降。再收集乙酸乙酯層至血清瓶中。重複以乙酸乙酯進行三次分層萃取,此為乙酸乙酯劃分(以下實驗稱EA組)。Ester extraction: Pour the water layer discharged into the beaker (i.e. the first water layer) back into the separatory funnel, add an equal volume of ethyl acetate for extraction, secure the lid and shake the separatory funnel vigorously to make the two immiscible. Mix the solution (during this period, you can open the stopcock to deflate as needed, about once every five shakes). Place the separatory funnel on a rack, open the lid and let it sit to allow the layers to separate. The denser water layer is at the bottom and the ethyl acetate layer is at the top. Let stand for about 10 minutes. Drain the aqueous layer back into the beaker and shake the separatory funnel slightly to allow the ethyl acetate layer to settle. Collect the ethyl acetate layer into a serum bottle. Repeat three layered extractions with ethyl acetate, which is the ethyl acetate partition (hereinafter referred to as EA group in the experiment).
醇類萃取:將排出至燒杯中的水層回溶液(即第二水層)倒回分液漏斗,加入等體積的丁醇進行萃取。栓好蓋子後將分液漏斗劇烈搖晃使兩不互溶的溶液混合(期間依需要可打開活栓排氣,大約每搖晃五次放氣一次),將分液漏斗置於架上,打開蓋子静置使分層。密度較大的水層回溶液在下方,上方為丁醇層。靜置時間約10分鐘。將水層回溶液排出至燒杯中,可稍微搖晃分液漏斗使丁醇層沉降。再收集丁醇層至血清瓶中。重複以丁醇進行三次分層萃取,此為丁醇劃分(以下實驗稱BU組或BuOH組)。Alcohol extraction: Pour the water layer returned to the solution (i.e. the second water layer) discharged into the beaker back into the separatory funnel, and add an equal volume of butanol for extraction. After tightening the lid, shake the separatory funnel vigorously to mix the two immiscible solutions (during this period, you can open the stopcock to deflate as needed, about once every five shakes). Place the separatory funnel on a stand, open the lid and let it sit. Make layers. The denser water layer is at the bottom, and the butanol layer is at the top. Let stand for about 10 minutes. Drain the water layer back into the beaker and shake the separatory funnel slightly to allow the butanol layer to settle. Collect the butanol layer into a serum bottle. Repeat three layered extractions with butanol, which is the butanol division (hereinafter referred to as the BU group or BuOH group in the experiment).
將剩餘的水層回溶液也收集至血清瓶中,為水劃分層 (即最終水層,以下實驗稱WA組或Water組)。將各個劃分層進行減壓濃縮,剩餘約20 mL時,將溶液轉移至褐色瓶 (褐色瓶需先烘乾秤重計為W1)。再將各劃分層進行減壓濃縮至乾,再將褐色瓶烘乾秤重計為W2,即可得知固形物重量(=W2-W1)。The remaining water layer solution was also collected into the serum bottle to divide the water into layers (i.e. the final water layer, referred to as the WA group or Water group in the following experiments). Concentrate each divided layer under reduced pressure. When about 20 mL remains, transfer the solution to a brown bottle (the brown bottle needs to be dried first and weighed as W1). Then concentrate each divided layer to dryness under reduced pressure, and then dry the brown bottle and weigh it as W2, and you can know the solid weight (=W2-W1).
實驗一:步驟 (A) 發芽製程中不同發芽天數所產生之台灣藜芽萃取物影響請參考第2圖,所繪示為本發明之台灣藜在步驟(A)發芽製程中,根據台灣藜發芽後不同天數共分為8組別(G0為發芽天數第0天(即尚未發芽)、G1為發芽後第1天、G2為發芽後第二天,以此類推)並再經步驟(B)接菌發酵製程(取第5天之發酵台灣藜芽)、步驟(C)萃取製程後(取最終水層WA組),分析各組別所產生的台灣藜芽萃取物之自由基清除效力。如第2圖中的(A)圖中,其顯示了不同天數組別的發芽狀態,從圖片可以觀察隨著天數增加,台灣藜發芽狀態良好且趨向一致,並無過密或過疏之情況,顯示實驗模型健康正常;在(B)圖中,橫軸為發芽天數(Germination time (days))第0天到第7天(G0~G7),縱軸為發芽率(Germinated rate (%)),從圖中可以看出隨著天數演進,約第2天到第3天即已全數發芽,顯示本實施例培植環境適宜台灣藜發芽;在(C)圖中,橫軸為發芽天數第0天到第7天(G0~G7),縱軸為芽長(Sprout length)(單位:公釐mm),其中統計上以G7、G6、G5、G4、G3為芽長最高群組(以a、b表示)、G2、G1為次高群族(以c、d表示)、G0則為對照組(以e表示),圖中顯示隨著天數演進,芽長亦等比例增加;在(D)圖中,橫軸為發芽天數第0天到第7天(G0~G7),縱軸為DPPH(α,α-Diphenyl-β-picrylhydrazyl)自由基清除效能,實驗步驟是將 DPPH之乙醇溶液配製濃度為0.1 mM並與樣品混合均勻(1:1, v/v)後在避光環境下靜置30分鐘,使最終濃度為0.2~7 mg 台灣藜芽萃取物/mL,經避光反應約30分鐘後以分光光度計(SpectraMax ®)測量517 nm 吸光值,其中DPPH自由基清除率(%)=(1-實驗組之吸光值/控制組之吸光值),另外額外配置0.01~0.1 mg/mL之Trolox(6-hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid)於同次實驗中作為反應之標準曲線,並以內插法換算單位樣品具有相同DPPH自由基清除能力之Trolox當量濃度(mg/mL),以總抗氧化能力(Trolox equivalent antioxidant capacity, TEAC)(mg TE/g)表示。在DPPH自由基清除效能上,統計上以G7、G6、G5、G4為最高群組(以a、ab、b表示),G3、G2為次高群組(以c、d表示),G1為不佳群組(以e表示),G0為對照組(以f表示)。由前述數值比較,可知隨著天數演進,在G3已可達相當之自由基清除效力,而在G4~G7之自由基清除效力則約略相同;在(E)圖中橫軸為發芽天數第0天到第7天(G0~G7),縱軸為ABTS(Azino-bis. (3-ethylbenzthiaoline)-6-sulfonic acid)自由基清除效能。實驗條件如下:製備7 mM ABTS溶液與2.45 mM過硫酸鉀(potassium persulfate, K 2S 8O 2)溶液,並將兩溶液等體積(1:1比例)預先混勻並於避光環境下12小時,其中ABTS自由基溶液於使用前以蒸餾水進行稀釋,直至734 nm波長下吸光值為0.7±0.02作為反應液。取20 μL之稀釋樣品萃取液與180 μL ABTS自由基反應液添加至96 well,混合反應6 分鐘後測定734 nm波長下之吸光值,ABTS清除率(%)=(1-實驗組之吸光值/控制組之吸光值) ,且額外配置0.01~0.1 mg/mL之Trolox於同次實驗中作為反應之標準曲線,換算單位樣品具有相同ABTS自由基清除能力之Trolox當量濃度(mg/mL),以總抗氧化能力(Trolox equivalent antioxidant capacity, TEAC)(mg TE/g)表示。統計上以G7、G6、G5、G4為最高群組(以a、b表示),G3、G2、G1為次高群組(以c、d表示),G0為對照組(以e表示)。由本圖可知,隨著天數演進,在G3已可達相當之自由基清除效力,而在G4~G7之自由基清除效力約略相同,與前述DPPH數據吻合。從第2圖之(A)~(E)圖可知,本發明在步驟(A)發芽製程中,在第4天之後(G4~G7)之自由基清除效力大致相同,因此在產品工業化製程講究時間效率下,選擇發芽後第4天之台灣藜芽可以達到最快速卻又不犧牲品質的效果。 Experiment 1: The influence of Taiwanese quinoa sprout extracts produced by different germination days in the germination process of step (A). Please refer to Figure 2, which shows the Taiwanese quinoa in the germination process of the present invention according to the germination of Taiwanese quinoa. After different days, they are divided into 8 groups (G0 is the 0th day of germination (that is, it has not yet germinated), G1 is the 1st day after germination, G2 is the second day after germination, and so on) and then goes through step (B) After the inoculation fermentation process (take the fermented Taiwanese quinoa sprouts on the 5th day) and the extraction process in step (C) (take the final water layer WA group), analyze the free radical scavenging effect of the Taiwanese quinoa sprout extract produced in each group. As shown in Figure 2 (A), it shows the germination status of different days groups. It can be observed from the picture that as the number of days increases, the germination status of Taiwanese pigweed is good and consistent, and there is no situation of being too dense or too sparse. It shows that the experimental model is healthy and normal; in the picture (B), the horizontal axis is the germination time (days) from day 0 to day 7 (G0~G7), and the vertical axis is the germination rate (%). , it can be seen from the figure that as the number of days evolves, all germination occurs from about the 2nd to the 3rd day, indicating that the cultivation environment of this embodiment is suitable for Taiwanese pigweed germination; in the figure (C), the horizontal axis is the 0th day of germination. From day to day 7 (G0~G7), the vertical axis is the sprout length (unit: mm), among which statistically G7, G6, G5, G4, and G3 are the groups with the highest sprout length (a , b), G2 and G1 are the second highest groups (represented by c, d), and G0 is the control group (represented by e). The figure shows that as the days progress, the bud length also increases in equal proportion; in (D ) In the figure, the horizontal axis is the germination days from day 0 to day 7 (G0~G7), and the vertical axis is the free radical scavenging efficiency of DPPH (α,α-Diphenyl-β-picrylhydrazyl). The experimental procedure is to mix the ethanol solution of DPPH Prepare a concentration of 0.1 mM and mix it with the sample evenly (1:1, v/v) and let it stand for 30 minutes in a dark environment to make the final concentration 0.2~7 mg Taiwanese Chenopodium bud extract/mL. After a light-proof reaction After about 30 minutes, measure the absorbance value at 517 nm with a spectrophotometer (SpectraMax ® ), where the DPPH free radical scavenging rate (%) = (1-absorbance value of the experimental group/absorbance value of the control group), and additionally configure 0.01~0.1 mg/mL of Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) was used as the standard curve of the reaction in the same experiment, and the unit sample was converted by interpolation method to have the same DPPH radical scavenging ability. The Trolox equivalent concentration (mg/mL) is expressed by the total antioxidant capacity (Trolox equivalent antioxidant capacity, TEAC) (mg TE/g). In terms of DPPH free radical scavenging efficiency, statistically G7, G6, G5, and G4 are the highest groups (represented by a, ab, b), G3 and G2 are the second highest groups (represented by c, d), and G1 is The poor group (represented by e), G0 is the control group (represented by f). From the comparison of the above values, it can be seen that as the number of days evolves, a comparable free radical scavenging effect has been achieved in G3, while the free radical scavenging effect in G4~G7 is approximately the same; in the figure (E), the horizontal axis is the 0th day of germination. From day to day 7 (G0~G7), the vertical axis is the free radical scavenging efficiency of ABTS (Azino-bis. (3-ethylbenzthiaoline)-6-sulfonic acid). The experimental conditions are as follows: prepare 7 mM ABTS solution and 2.45 mM potassium persulfate (K 2 S 8 O 2 ) solution, mix the two solutions in equal volumes (1:1 ratio) in advance and store in a light-proof environment for 12 hours, the ABTS free radical solution was diluted with distilled water before use until the absorbance value at 734 nm was 0.7±0.02 as the reaction solution. Take 20 μL of the diluted sample extract and 180 μL of the ABTS free radical reaction solution and add it to 96 well. After mixing and reacting for 6 minutes, measure the absorbance value at the wavelength of 734 nm. ABTS clearance rate (%) = (1-absorbance value of the experimental group) /absorbance value of the control group), and additionally configure 0.01~0.1 mg/mL Trolox as the standard curve of the reaction in the same experiment, and convert the Trolox equivalent concentration (mg/mL) of the unit sample with the same ABTS free radical scavenging ability, Expressed as total antioxidant capacity (Trolox equivalent antioxidant capacity, TEAC) (mg TE/g). Statistically, G7, G6, G5, and G4 are the highest groups (represented by a and b), G3, G2, and G1 are the second highest groups (represented by c and d), and G0 is the control group (represented by e). It can be seen from this figure that as the days progress, a comparable free radical scavenging effect has been achieved in G3, while the free radical scavenging effect in G4~G7 is approximately the same, which is consistent with the aforementioned DPPH data. As can be seen from Figure 2 (A) ~ (E), in the germination process of step (A) of the present invention, the free radical scavenging effect after the 4th day (G4 ~ G7) is roughly the same. Therefore, the industrialization process of the product should be paid attention to. In terms of time efficiency, choosing Taiwanese quinoa sprouts on the 4th day after germination can achieve the fastest results without sacrificing quality.
實驗二:步驟 (B) 接菌發酵製程中不同發酵天數所產生之台灣藜芽萃取物影響請參考第3圖,所繪示為本發明之台灣藜在步驟(A)發芽製程後(取第4天之台灣藜芽),再經步驟(B)接菌發酵製程,其中依照台灣藜芽之接菌發酵天數共劃分為11組別(PF0為接菌發酵第0天(即尚未接菌發酵)、PF1為接菌發酵第1天、PF2為接菌發酵後第2天,以此類推),後續經步驟(C)萃取製程(取最終水層WA組),最後分析各組別所產生的台灣藜芽萃取物之自由基清除效力。在第3圖中的(A)圖中,其顯示不同天數組別的接菌發酵狀態,觀察其圖片可知:在PF0時台灣藜芽均勻地分佈在培養平板上,而隨著天數增加,台灣藜芽植入孢子液後約略在PF2即布滿整個培養基質,並且均勻密佈地與台灣藜芽產生交互發酵之情況,圖片顯示接菌發酵狀態良好;在(B)圖中,橫軸為接菌發酵天數第0天到第10天(PF0~PF10),縱軸為DPPH自由基清除效能(實驗步驟與前述第2圖(D)相同),在DPPH自由基清除效能上,統計上以PF2、PF3為最高群組(以a、ab表示),PF4、PF5、PF6為次高群組(以bc表示),PF1與PF7為次次佳群組(以cd表示),PF8、PF9、PF10為不佳群組(以d表示),PF0為對照組(以d表示),從前述數據可知:在接菌發酵初期由於發酵時間不足並無法達到良好台灣藜芽萃取物DPPH自由基清除效能,而在發酵一定時間後(PF2~PF6)皆可達相當之自由基清除效力,但經過久時間(PF7~PF10)則自由基清除能力下降;在(C)圖中,橫軸為接菌發酵天數第0天到第10天(PF0~PF10),縱軸為ABTS自由基清除效能,在ABTS自由基清除效能上,統計上以PF3、PF2、PF5、PF4、PF6、PF7為最高群組(以a、ab、b表示),PF9、PF8、PF10為次高群組(以c、cd表示),PF1為不佳群組(以de表示),PF0為對照組(以e表示),從前述數據可知:在接菌發酵初期由於發酵時間不足並無法達到良好台灣藜芽萃取物ABTS自由基清除效能,而在發酵一定時間後(PF2~PF7)皆可達相當之自由基清除效力,但經過久時間(PF8~PF10)則自由基清除能力下降,與前述DPPH之數據吻合。從第3圖之(A)~(C)圖可知,本發明在步驟(B)接菌發酵製程中,自由基清除效力約在第2天至第7天尤佳,而在在產品工業化製程講究時間效率下,綜合考量以接菌發酵後第5天之發酵台灣藜芽可以達到最快速卻又不犧牲品質的效果。 Experiment 2: The influence of Taiwanese quinoa sprout extract produced by different fermentation days in the inoculation fermentation process of step (B) . Please refer to Figure 3, which shows the Taiwanese quinoa of the present invention after the germination process of step (A) (take the 4-day-old Taiwanese quinoa buds), and then go through step (B) of the inoculation and fermentation process, which is divided into 11 groups according to the number of days of inoculation and fermentation of Taiwanese quinoa buds (PF0 is the 0th day of inoculation and fermentation (that is, it has not yet been inoculated and fermented). ), PF1 is the first day of inoculated fermentation, PF2 is the second day after inoculated fermentation, and so on), followed by step (C) extraction process (take the final water layer WA group), and finally analyze the products produced by each group Free radical scavenging effect of Taiwanese quinoa sprout extract. In Figure 3 (A), it shows the fermentation status of different groups of days. Observing the picture, we can see that at PF0, Taiwanese quinoa buds are evenly distributed on the culture plate, and as the number of days increases, Taiwanese quinoa buds are evenly distributed on the culture plate. After the Chenopodium quinoa buds were implanted into the spore liquid, they covered the entire culture medium at approximately PF2, and evenly and densely interfered with the Taiwan Chenopodium buds for interactive fermentation. The picture shows that the fermentation state of the inoculated bacteria is good; in (B), the horizontal axis is the fermentation state of the inoculated bacteria. The bacterial fermentation days are from day 0 to day 10 (PF0~PF10). The vertical axis is the DPPH free radical scavenging efficiency (the experimental procedure is the same as the aforementioned Figure 2 (D)). In terms of DPPH free radical scavenging efficiency, statistically speaking, PF2 , PF3 is the highest group (expressed by a, ab), PF4, PF5, and PF6 are the second highest groups (expressed by bc), PF1 and PF7 are the second best groups (expressed by cd), PF8, PF9, and PF10 is the unsatisfactory group (expressed by d), and PF0 is the control group (expressed by d). From the above data, it can be seen that in the early stage of inoculation fermentation, due to insufficient fermentation time, good Taiwanese quinoa sprout extract DPPH free radical scavenging performance cannot be achieved. After a certain period of fermentation (PF2~PF6), a considerable free radical scavenging effect can be achieved, but after a long time (PF7~PF10), the free radical scavenging ability decreases; in the picture (C), the horizontal axis represents the inoculated fermentation. From day 0 to day 10 (PF0~PF10), the vertical axis is ABTS free radical scavenging efficiency. In terms of ABTS free radical scavenging efficiency, statistically speaking, PF3, PF2, PF5, PF4, PF6, and PF7 are the highest groups ( Indicated by a, ab, b), PF9, PF8, and PF10 are the second highest group (indicated by c, cd), PF1 is the poor group (indicated by de), and PF0 is the control group (indicated by e). From From the above data, it can be seen that in the early stage of inoculation fermentation, due to insufficient fermentation time, the ABTS free radical scavenging effect of Taiwan Chenopodium quinoa bud extract cannot be achieved. However, after a certain period of fermentation (PF2~PF7), it can achieve a comparable free radical scavenging effect. However, After a long time (PF8~PF10), the free radical scavenging ability decreases, which is consistent with the aforementioned data of DPPH. It can be seen from Figure 3 (A) ~ (C) that in the inoculation fermentation process of step (B) of the present invention, the free radical scavenging effect is particularly good from about the 2nd to the 7th day, and in the industrialized process of the product Paying attention to time efficiency, taking comprehensive considerations into fermenting Taiwanese quinoa sprouts on the 5th day after inoculation and fermentation can achieve the fastest effect without sacrificing quality.
實驗三:台灣藜芽萃取物之抗氧化功效測試使用TEAC法測試四組樣品的抗氧化能力(DPPH與ABTS)。DPPH抗氧化實驗流程如下:將 DPPH之乙醇溶液配製濃度為0.1mM並與樣品混合均勻(1:1, v/v)後在避光環境下靜置30分鐘,使最終濃度為0.2~7 mg 台灣藜芽萃取物/mL,經避光反應約30分鐘後以分光光度計(SpectraMax
®)測量517 nm 吸值,其中DPPH自由基清除率(%)=(1-實驗組之吸光值/控制組之吸光值),另外額外配置0.01~0.1 mg/mL之Trolox(6-hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid)於同次實驗中作為反應之標準曲線,並以內插法換算單位樣品具有相同DPPH自由基清除能力之Trolox當量濃度(mg/mL),以總抗氧化能力(Trolox equivalent antioxidant capacity, TEAC)(mg TE/g)表示。ABTS抗氧化實驗步驟如下:製備7 mM ABTS(Azino-bis. (3-ethylbenzthiaoline)-6-sulfonic acid)溶液與2.45 mM過硫酸鉀(potassium persulfate, K
2S
8O
2)溶液,並將兩溶液等體積(1:1比例)預先混勻12小時,其中ABTS自由基溶液於使用前以蒸餾水進行稀釋,直至734 nm波長下吸光值為0.7±0.02作為反應液。取20 μL之稀釋樣品萃取液與180 μL ABTS自由基反應液添加至96 well,混合反應6 分鐘後測定734 nm波長下之吸光值,且額外配置0.01~0.1 mg/mL之Trolox於同次實驗中作為反應之標準曲線,換算單位樣品具有相同ABTS自由基清除能力之Trolox當量濃度(mg/mL),以總抗氧化能力(Trolox equivalent antioxidant capacity, TEAC)(mg TE/g)表示。由下方表1結果顯示,在DPPH抗氧化實驗中,「BU」組具有最佳的抗氧化能力(以a表示),「EA」組次之(以b表示),「WA」組第三(以c表示),「HEX」組最後(以d表示)。於ABST抗氧化實驗中,「WA」組具有最好的抗氧化能力(以a表示),「BU」組次之(以b表示),「HEX」組第三(以c表示),「EA」組最末(以d表示)。
表1 台灣藜芽萃取物抗氧化試驗
實驗四:台灣藜芽萃取物之安全性測試本實驗以CCK-8 (Dojindo laboratories, Kumamoto, Japan)來測試八組不同濃度(25 ppm與50 ppm)之台灣藜芽萃取物(「Hex」、「EA」、「BuOH」與「Water」)之安全性。實驗步驟如下:實驗時取100 μL的細胞懸浮液以10 5cells/mL之細胞濃度種入96孔盤中,於37℃、5%CO 2培養箱培養24小時後移除培養液,細胞用 10% CCK-8 溶液染色並培養 1 小時。使用 Elisa Reader (MULTISKAN GO,Thermo Fisher Scientific,Waltham,MA,USA) 在 450 nm 處測量吸光度,並使用以下公式計算細胞活力:細胞活力 = (OD 450樣本/OD 450對照) x 100%。 Experiment 4: Safety test of Taiwanese quinoa sprout extract. This experiment used CCK-8 (Dojindo laboratories, Kumamoto, Japan) to test eight groups of Taiwanese quinoa sprout extract (“Hex”, The safety of "EA", "BuOH" and "Water"). The experimental steps are as follows: During the experiment, take 100 μL of cell suspension and seed it into a 96-well plate at a cell concentration of 10 5 cells/mL. Cultivate it in a 37°C, 5% CO 2 incubator for 24 hours. After that, remove the culture medium and use the cells. Stain with 10% CCK-8 solution and incubate for 1 hour. Absorbance was measured at 450 nm using an Elisa Reader (MULTISKAN GO, Thermo Fisher Scientific, Waltham, MA, USA) and cell viability was calculated using the following formula: Cell viability = (OD 450 sample/OD 450 control) x 100%.
請參考第4圖,所繪示為本發明台灣藜芽萃取物之毒性與劑量測試之長條圖,其中橫軸為各組別,縱軸為細胞存活率(cell viability, 單位:%)。如第4圖所示,在八組台灣藜芽萃取物中,相較對照組(Control, CTRL組)之存活率(100%),「Water」組別在25 ppm的濃度下有最好的細胞存活率 (以a表示),50 ppm的濃度次之(以ab表示),其餘組別皆不如上述兩組,顯見「Water」組別之安全性最佳。Please refer to Figure 4, which shows a bar chart of the toxicity and dose test of the Taiwanese quinoa sprout extract of the present invention, in which the horizontal axis represents each group and the vertical axis represents cell viability (unit: %). As shown in Figure 4, among the eight groups of Taiwanese quinoa sprout extracts, compared with the survival rate (100%) of the control group (Control, CTRL group), the "Water" group has the best survival rate at a concentration of 25 ppm. The cell survival rate (expressed as a) was followed by the concentration of 50 ppm (expressed as ab), and the other groups were not as good as the above two groups. It is obvious that the "Water" group has the best safety.
實驗五:台灣藜芽萃取物之抑制 PM2.5 誘導之 ROS 生成量與回復細胞活力測試PM2.5購自Sigma-Aldrich公司(現為Merck子公司),編號為CRM558,成分如表2所示。
表2
實驗中所使用之PM2.5以10,000 μg/mL為濃度溶於PBS中,配置成儲備原液。進行細胞處理時,先以超音波震盪處理30分鐘,再以細胞培養液稀釋為目標濃度進行實驗。進行實驗時,將MHS細胞(一種肺泡細胞)以1×10 4/well接種至96孔盤,放入37℃恆溫培養箱培養24小時,待細胞貼附後將培養基除去,加入25 ppm的台灣藜芽萃取物「WA」、「BU」、「HEX」與「EA」組處理24小時後,去除培養基,換上一般培養基。 The PM2.5 used in the experiment was dissolved in PBS at a concentration of 10,000 μg/mL and prepared as a stock solution. When processing cells, first use ultrasonic shock for 30 minutes, and then conduct experiments with the cell culture medium diluted as the target concentration. During the experiment, MHS cells (a type of alveolar cells) were inoculated into a 96-well plate at 1×10 4 /well and cultured in a 37°C constant-temperature incubator for 24 hours. After the cells were attached, the medium was removed and 25 ppm Taiwanese After treatment for 24 hours in the "WA", "BU", "HEX" and "EA" groups of Chenopodium bud extracts, the culture medium was removed and replaced with the general culture medium.
請參考第5圖,所繪示為本發明台灣藜芽萃取物之抑制PM2.5誘導之ROS生成量與回復細胞活力測試圖,其中(A)圖為細胞顯微鏡圖,又左邊部分為一般顯微鏡圖,右邊部分為活性氧化物質(Reactive oxygen species, ROS)螢光顯微鏡圖;(B)圖為根據(A)圖中細胞數量以及螢光強度經量化計算所得數值之長條圖,其中分組如下:對照組(Control, CTRL組)、0 μg/mL之PM2.5(僅加入PBS, VEH組)、200 μg/mL之PM2.5(200PM組)、200 μg/mL之PM2.5+0.5 mM N-乙醯半胱氨酸(N-acetyl cysteine, NAC)(200PM+NAC組)、200 μg/mL之PM2.5+25 ppm之「BU」萃取物(200PM+bu25組)、200 μg/mL之PM2.5+25 ppm之「EA」萃取物(200PM+EA25組)、200 μg/mL之PM2.5+25 ppm之「HEX」萃取物(200PM+hex25)、200 μg/mL之PM2.5+25 ppm之「WA」萃取物(200PM+Water25);(C)圖為根據(A)圖中細胞數量的將量化經算所得數值之長條圖(以CTRL為100%),其中分組如下:對照組(Control, CTRL組)、0 μg/mL之PM2.5(僅加入PBS, VEH組)、200 μg/mL之PM2.5(PM組)、200 μg/mL之PM2.5+0.5 mM N-乙醯半胱氨酸 (PM+NAC組)、200 μg/mL之PM2.5+25 ppm之「BU」萃取物(BU組)、200 μg/mL之PM2.5+25 ppm之「EA」萃取物(EA組)、200 μg/mL之PM2.5+25 ppm之「HEX」萃取物(HEX組)、200 μg/mL之PM2.5+25 ppm之「WA」萃取物(WA組)。Please refer to Figure 5, which shows the test chart of the Taiwan Chenopodium quinoa sprout extract of the present invention for inhibiting PM2.5-induced ROS production and restoring cell viability. Picture (A) is a cell microscope picture, and the left part is a general microscope. Figure, the right part is a fluorescence microscope image of reactive oxygen species (ROS); Figure (B) is a bar chart of values calculated based on the number of cells and fluorescence intensity in Figure (A), which are grouped as follows : Control group (Control, CTRL group), 0 μg/mL PM2.5 (PBS only, VEH group), 200 μg/mL PM2.5 (200PM group), 200 μg/mL PM2.5+0.5 mM N-acetyl cysteine (NAC) (200PM+NAC group), 200 μg/mL PM2.5+25 ppm "BU" extract (200PM+bu25 group), 200 μg /mL of PM2.5+25 ppm "EA" extract (200PM+EA25 group), 200 μg/mL of PM2.5+25 ppm "HEX" extract (200PM+hex25), 200 μg/mL of PM2.5+25 ppm "WA" extract (200PM+Water25); (C) is a bar graph of the calculated values based on the quantification of the number of cells in (A) (CTRL is 100%), The groups are as follows: control group (Control, CTRL group), 0 μg/mL PM2.5 (PBS only, VEH group), 200 μg/mL PM2.5 (PM group), 200 μg/mL PM2. 5+0.5 mM N-acetyl cysteine (PM+NAC group), 200 μg/mL PM2.5+25 ppm "BU" extract (BU group), 200 μg/mL PM2.5+ 25 ppm "EA" extract (EA group), 200 μg/mL PM2.5+25 ppm "HEX" extract (HEX group), 200 μg/mL PM2.5+25 ppm "WA" Extracts (Group WA).
如第5(B)圖所示,在ROS的生成量上「200PM+Water25」、「200PM+EA25」與「200PM+bu25」組別皆有較低的ROS生成量,接近於對照組(CTRL組),「200PM+hex25」有較高的ROS生成量,接近於只加入PM2.5組別(200PM組)。如5(C)圖所示,在細胞存活率上,「WA」組最接近對照組(CTRL組),其餘組別皆不理想。由此可見,「WA」組別可顯著降低PM2.5帶來的ROS傷害並提升細胞存活率,對於減少PM2.5對細胞帶來的傷害有顯著作用。As shown in Figure 5(B), in terms of ROS generation, the "200PM+Water25", "200PM+EA25" and "200PM+bu25" groups all have lower ROS generation, which is close to the control group (CTRL group), "200PM+hex25" has a higher ROS generation amount, which is close to only joining the PM2.5 group (200PM group). As shown in Figure 5(C), in terms of cell survival rate, the "WA" group is closest to the control group (CTRL group), and the other groups are not ideal. It can be seen that the "WA" group can significantly reduce the ROS damage caused by PM2.5 and improve the cell survival rate, which has a significant effect on reducing the damage caused by PM2.5 to cells.
實驗六:台灣藜芽萃取物之「 WA 」組別之抗發炎功效本實驗進一步針對台灣藜芽萃取物之「WA」組別研究其發炎/抗發炎相關路徑(NF-κB路徑)蛋白質之調控。請參考第6圖,所繪示為本發明台灣藜芽萃取物之「WA」組別對於PM2.5誘導MHS細胞後NF-κB蛋白質表現量之示意圖,其中上半部為NF-κB p65與Ser536磷酸化NF-κB p65蛋白質西方墨點圖,下半部為根據西方墨點法圖換算之磷酸化比例(p-NF-κB p65/NF-κB p65)。如第6圖所示,在經過PM2.5之處理後(PM組),MHS細胞的NF-κB磷酸化比例相較於對照組(CTRL組)有顯著增加,而在PM2.5加上台灣藜芽萃取物之「WA」組別同時處理後(PM+WA組),MHS細胞的NF-κB磷酸化比例相較於前述PM 2.5處理(PM組)則明顯下降,甚至接近於對照組(CTRL組),代表本發明台灣藜芽萃取物之「WA」組別能有效抑制NF-κB之磷酸化。 Experiment 6: The anti-inflammatory effect of the " WA " group of Taiwanese quinoa sprout extract. This experiment further studies the regulation of inflammation/anti-inflammatory related pathway (NF-κB pathway) proteins of the "WA" group of Taiwanese quinoa sprout extract. . Please refer to Figure 6, which is a schematic diagram showing the expression of NF-κB protein in MHS cells induced by PM2.5 in the "WA" group of Taiwanese quinoa bud extract of the present invention. The upper part is NF-κB p65 and Western blot diagram of Ser536 phosphorylated NF-κB p65 protein. The lower half shows the phosphorylation ratio (p-NF-κB p65/NF-κB p65) converted according to the Western blot diagram. As shown in Figure 6, after treatment with PM2.5 (PM group), the NF-κB phosphorylation ratio of MHS cells increased significantly compared with the control group (CTRL group), and after PM2.5 plus Taiwan After simultaneous treatment with the "WA" group of Chenopodium quinoa bud extract (PM+WA group), the NF-κB phosphorylation ratio of MHS cells was significantly reduced compared to the aforementioned PM 2.5 treatment (PM group), and was even close to that of the control group ( CTRL group), representing the "WA" group of the Taiwanese quinoa sprout extract of the present invention, which can effectively inhibit the phosphorylation of NF-κB.
又請參考第7圖,所繪示為本發明台灣藜芽萃取物之「WA」組別對於PM2.5誘導MHS細胞後發炎基因與抗發炎基因表現量之示意圖,其中橫軸之IL1B(Interleukin-1beta,白血球介素1β)、IL6(Interleukin-6,白血球介素6)、TNFa(Tumor Necrosis Factor,腫瘤壞死因子)具有促進發炎的功效,IL1Ra(Interleukin 1 receptor antagonist,白血球介素1受體拮抗劑)與IL10(白血球介素10)具有抑制發炎的功效,而縱軸表示上述蛋白質的mRNA表現量(對比於對照組CTRL比例)。如第7圖所示,在經過PM 2.5之處理後(PM組),MHS細胞中發炎蛋白質IL1B、IL6與TNFa之mRNA表現量相較於對照組(CTRL組)有顯著增加,抗發炎蛋白質IL1Ra與IL10之mRNA表現量則下降;但在PM2.5加上台灣藜芽萃取物之「WA」組別同時處理後(WA組),卻能降低發炎蛋白質IL1B、IL6與TNFa之mRNA表現量,而能提升抗發炎蛋白質IL10之mRNA表現量。本實驗可證明本發明台灣藜芽萃取物之「WA」組別能有效抑制抑制PM2.5所帶來的不良發炎結果,故具有抗發炎之功效。Please also refer to Figure 7, which is a schematic diagram showing the expression of inflammatory genes and anti-inflammatory genes after PM2.5 induces MHS cells in the "WA" group of Taiwanese quinoa sprout extract of the present invention, in which the horizontal axis IL1B (Interleukin -1beta, interleukin 1β), IL6 (Interleukin-6, interleukin 6), TNFa (Tumor Necrosis Factor, tumor necrosis factor) have the effect of promoting inflammation, IL1Ra (Interleukin 1 receptor antagonist, interleukin 1 receptor Antagonist) and IL10 (leukin 10) have the effect of inhibiting inflammation, and the vertical axis represents the mRNA expression amount of the above proteins (compared to the CTRL ratio in the control group). As shown in Figure 7, after treatment with PM 2.5 (PM group), the mRNA expression levels of the inflammatory proteins IL1B, IL6 and TNFa in MHS cells increased significantly compared with the control group (CTRL group), and the anti-inflammatory protein IL1Ra The mRNA expression levels of IL10 and IL10 decreased; however, after simultaneous treatment with PM2.5 and the "WA" group of Taiwanese quinoa sprout extract (WA group), the mRNA expression levels of inflammatory proteins IL1B, IL6, and TNFa were reduced. It can increase the expression of mRNA of the anti-inflammatory protein IL10. This experiment can prove that the "WA" group of the Taiwanese quinoa sprout extract of the present invention can effectively inhibit the adverse inflammatory consequences caused by PM2.5, and therefore has anti-inflammatory effects.
實驗七:台灣藜芽萃取物之「 WA 」組別之成分分析本發明針對台灣藜芽萃取物之「WA」組別進行成分分析,可以得到如表3之成分與比例表(於25 ppm有效萃取劑量下測定) 。
表3 台灣藜芽萃取物之「WA」組別成分鑑定
由上表可知,焦麩胺酸、葡萄糖酸、尿苷、蘋果酸、黃嘌呤核苷、3-羥基-3-甲基戊二酸、乙醯左旋肉鹼、泛酸與4-羥脯氨酸,皆為有效抗發炎物質,顯見本發明台灣藜芽萃取物之「WA」組別確實有抗發炎潛力。As can be seen from the above table, pyroglutamic acid, gluconic acid, uridine, malic acid, xanthine nucleoside, 3-hydroxy-3-methylglutaric acid, acetyl-L-carnitine, pantothenic acid and 4-hydroxyproline , are all effective anti-inflammatory substances. It is obvious that the "WA" group of the Taiwanese quinoa sprout extract of the present invention does have anti-inflammatory potential.
綜上所述,本發明台灣藜芽萃取物之「WA」組別不僅是透過特殊的製備方法,且經實驗證實具有抗氧化、抵抗因PM2.5引起之細胞毒性、細胞發炎等功效,並可用於製備用來治療由PM2.5所引發的發炎反應的藥物。In summary, the "WA" group of Taiwanese quinoa sprout extract of the present invention is not only prepared through a special preparation method, but also has been experimentally proven to have the effects of antioxidant, resisting cytotoxicity and cell inflammation caused by PM2.5, and It can be used to prepare drugs for treating inflammatory reactions caused by PM2.5.
無without
第1圖所繪示為本發明生物反應器之一實施例的示意圖。 第2圖所繪示為本發明之台灣藜在步驟(A)發芽製程中,根據台灣藜發芽後不同天數共分為8個組別,再經步驟(B)接菌發酵製程與步驟(C)萃取製程後,各組別所產生的台灣藜芽萃取物狀況。 第3圖所繪示為本發明之台灣藜在步驟(A)發芽製程後,再經步驟(B)接菌發酵製程,其中依照台灣藜芽之接菌發酵天數劃分為為11個組別,後續經步驟(C)萃取製程,各組別所產生的台灣藜芽萃取物狀況。 第4圖所繪示為本發明台灣藜芽萃取物之毒性與劑量測試之長條圖。 第5圖所繪示為本發明台灣藜芽萃取物之抑制PM2.5誘導之ROS生成量與回復細胞活力測試圖。 第6圖所繪示為本發明台灣藜芽萃取物之「WA」組別對於PM2.5誘導MHS細胞後NF-κB蛋白質表現量之示意圖。 第7圖所繪示為本發明台灣藜芽萃取物之「WA」組別對於PM2.5誘導MHS細胞後發炎基因與抗發炎基因表現量之示意圖。 Figure 1 is a schematic diagram of an embodiment of a bioreactor of the present invention. Figure 2 shows the Taiwanese quinoa in the germination process of step (A) of the present invention, which is divided into 8 groups according to different days after germination of Taiwanese quinoa, and then undergoes the inoculation fermentation process of step (B) and the step (C). ), the status of Taiwanese quinoa sprout extract produced by each group after the extraction process. Figure 3 shows the Taiwanese quinoa of the present invention after the germination process in step (A), and then the inoculation and fermentation process in step (B). The Taiwanese quinoa buds are divided into 11 groups according to the number of days of inoculation and fermentation. The status of the Taiwanese quinoa sprout extract produced by each group after the subsequent extraction process in step (C). Figure 4 shows a bar chart of the toxicity and dose tests of the Taiwanese quinoa sprout extract of the present invention. Figure 5 shows a test chart of the inhibition of PM2.5-induced ROS production and restoration of cell viability by the Taiwanese quinoa sprout extract of the present invention. Figure 6 shows a schematic diagram of the expression of NF-κB protein in MHS cells induced by PM2.5 in the "WA" group of Taiwanese quinoa sprout extract of the present invention. Figure 7 shows a schematic diagram of the expression of inflammatory genes and anti-inflammatory genes after PM2.5 induces MHS cells in the "WA" group of Taiwanese quinoa sprout extract of the present invention.
Claims (14)
Publications (1)
Publication Number | Publication Date |
---|---|
TWI834477B true TWI834477B (en) | 2024-03-01 |
Family
ID=
Non-Patent Citations (1)
Title |
---|
專書 呂姵穎 「台灣藜蛋白質經發芽和酵素水解後其抗氧化能力及抗菌能力之探討」 碩士論文 國立宜蘭大學食品科學系 紙本論文上架日:2020/10/15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8357406B2 (en) | Method for preparing raw material for functional foods from barley or wheat seeds | |
KR101439521B1 (en) | Rice wine made from Sorghum and A method of making the same | |
CN102369289A (en) | Method for increasing concentration of avenanthramides in oats | |
CN111329049B (en) | Preparation method of quinoa and highland barley enzyme powder | |
CN107043709B (en) | Method for preparing polysaccharide red yeast rice germinated rice by solid state fermentation and product | |
TW201507600A (en) | The method for culturing antrodia cinnamomea | |
CN104560608B (en) | Red-color dragon fruit vinegar processing process | |
CN109123647B (en) | Preparation method of black barley enzyme capable of effectively enriching gamma-aminobutyric acid and polyphenol | |
KR20190104817A (en) | Method for manufacturing germinated oats extract having high-content avenanthramides | |
US9161495B2 (en) | Method for preparing raw material for functional foods from barley or wheat seeds | |
CN109593630B (en) | Fermented seedless wampee vinegar and preparation method and application thereof | |
US20110229604A1 (en) | Momordica Wine | |
TWI834477B (en) | Extract of chenopodium formosanum koidz., preperation method thereof and use for anti-oxidation, anti-cytotoxicity and anti-inflammation | |
CN110547441B (en) | Preparation method of germinated wheat soy sauce and product | |
CN108901587A (en) | A kind of solid culture method of cicada fungus | |
WO2012165735A1 (en) | Pharmaceutical composition containing mushroom mycelium rice extract for treating diabetes or obesity | |
TWI683664B (en) | Actinidia chinensis planch. fermented extracts and the use thereof in a composition for increasing the antioxidant activity, increasing the anti-glycation activity, increasing the activity of proteolytic enzymes, improving the gastrointestinal dyspepsia, and increasing the gastrointestinal flora diversity | |
CN111557424A (en) | Method for improving antioxidant capacity of germinated quinoa by magnetic field treatment | |
WO2002071873A1 (en) | Functional cereals | |
TWI704873B (en) | Process for preparing a fermentation product and the fermentation products prepared therefrom and its applications | |
KR20180106968A (en) | Herb vinegar and manufacturing method thereof | |
CN100448475C (en) | Dry concentrate of yellow wine and preparation method thereof | |
Cao et al. | Improving biomass and dendrobine-type total alkaloids (DTTAs) production of Dendrobium nobile through combining Temporary Immersion Bioreactor System (TIBS) with endophyte MD33 elicitation | |
CN112137024A (en) | Fullerene germinated grain and preparation method and application thereof | |
JP2021518442A (en) | Black rice germination solution with anti-inflammatory effect and its manufacturing method |